Investigating the essential roles of Ubiquitin-like molecules and the Ubiquitin Proteasome System


Ubiquigent is a biotechnology company developing reagents, kits and drug discovery services for the research community that will help investigators unravel the complexity of and pursue new therapeutic target opportunities within the Ubiquitin Proteasome Pathway (UPP). The company’s lab and service operations are adjacent to the Protein Ubiquitylation Unit (PUU), part of the Scottish Institute for Cell Signalling based at the University of Dundee, Scotland, UK.



Jason Brown